VP
VERTEX PHARMACEUTICALS INC
VRTX· Health Care· BiotechnologyS&P 500
Close · 16/09/2026
513.26
1D
-0.27%52-week range
374.17 – 560.25
Volume
6,38,200.00
Price history
VRTX
17/08/2026 to 16/09/2026
O 513.80 H 517.95 L 511.35
1W-1.51%
1M-0.44%
3M+13.26%
6M+10.98%
1Y+30.53%
3Y+47.82%
5Y+168.20%
MAX+159.37%
Fundamentals
as of 16/09/2026- Market cap
- $130.09B
- Shares out
- 253.46M
- P/E (trailing)
- 29.53
- P/E (forward)
- 25.60
- EPS (trailing)
- 17.38
- Beta
- 0.32
- Profit margin
- 35.00%
- P/B
- 6.42
- Return on equity
- 21.76%
SEC financial statements
65 quarterly and 18 annual periods through 30/06/2026.
Details
- Ticker
- VRTX
- Index
- SP500
- Sector
- Health Care
- Industry
- Biotechnology
- HQ
- -
Last close 16/09/2026.
Tracked by Congress
10 filers · 1 on watchlist · 7 buys · 11 sells · ?: 2 · D: 2 · R: 14
- 26/08/2026David J. TaylorSellVertex Pharmaceuticals Incorporated - Common Stock$1,001–$15,000
- 03/05/2024Thomas H TubervilleWSellVertex Pharmaceuticals Incorporated - Common Stock$1,001–$15,000
- 27/03/2026Alan ArmstrongBuyVertex Pharmaceuticals Incorporated - Common Stock$1,001–$15,000
- 29/01/2026David J. TaylorSellVertex Pharmaceuticals Incorporated - Common Stock$1,001–$15,000
- 23/10/2024Julia LetlowBuyVertex Pharmaceuticals Incorporated - Common Stock$1,001–$15,000
- 07/08/2025David J. TaylorBuyVertex Pharmaceuticals Incorporated - Common Stock$1,001–$15,000
- 11/06/2025Lisa McClainSellVertex Pharmaceuticals Incorporated - Common Stock$1,001–$15,000
- 10/06/2025Lisa McClainSell+Vertex Pharmaceuticals Incorporated - Common Stock$1,001–$15,000